Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-08 Purchase |
2022-07-13 9:27 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
19,270,476 | $2.2 | $42,395,047 | 76,616,270 (Indirect Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:11 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Wagner Kristie Ann VP, Principal Fin & Acct Off |
80,500 | $0 | $0 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:10 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Triola Anna Diaz Chief Commercial Officer |
125,000 | $0 | $0 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:09 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer |
150,000 | $0 | $0 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:09 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG |
150,000 | $0 | $0 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:08 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO |
478,500 | $0 | $0 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:07 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer |
150,000 | $0 | $0 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:07 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
27,500 | $2.2 | $60,500 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:06 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director |
27,500 | $2.2 | $60,500 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:06 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel |
150,000 | $0 | $0 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:05 pm |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
27,500 | $2.2 | $60,500 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:04 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Berger Heather A. Director |
27,500 | $2.2 | $60,500 | 0 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:03 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer |
150,000 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-11 Other |
2022-07-11 4:11 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Wagner Kristie Ann VP, Principal Fin & Acct Off |
73,400 | $0 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:10 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Triola Anna Diaz Chief Commercial Officer |
100,000 | $0 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer |
180,023 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer |
39,596 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG |
88,333 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG |
17,572 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:08 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO |
723,738 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:08 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO |
56,072 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:07 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer |
169,043 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:07 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer |
17,092 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:07 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
28,307 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:07 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
22,000 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:06 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director |
23,500 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:06 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director |
22,000 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:06 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel |
70,833 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:06 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel |
17,572 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
37,583 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
22,000 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:04 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Berger Heather A. Director |
28,307 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:04 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Berger Heather A. Director |
22,000 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:03 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer |
142,307 | $0 | 0 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:03 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer |
17,572 | $2.2 | 0 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-25 4:30 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Wagner Kristie Ann VP, Principal Fin & Acct Off |
10,000 | $0 | 80,500 (Direct) |
View |
Ownership |
2022-02-25 4:30 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Wagner Kristie Ann VP, Principal Fin & Acct Off |
0 | $0 | 143,900 (Direct) |
View |
| 2022-02-18 Other |
2022-02-23 1:05 pm |
N/A 2022-08-18 |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
0 | $0 | 57,345,794 (Indirect) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:05 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer |
98,700 | $0 | 98,700 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:05 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Gutch Michael See Remarks |
75,404 | $0 | 75,404 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:04 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
33,333 | $0 | 33,333 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:04 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO |
326,114 | $0 | 326,114 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:03 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer |
75,698 | $0 | 75,698 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:03 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:02 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
17,307 | $0 | 17,307 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:02 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Behanna Heather Director |
17,307 | $0 | 17,307 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:01 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer |
92 | $0 | 92,307 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:01 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
26,583 | $0 | 26,583 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:00 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel |
20,833 | $0 | 20,833 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer |
125,000 | $0 | 189,596 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Gutch Michael See Remarks |
125,000 | $0 | 167,572 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:04 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
125,000 | $0 | 167,572 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:04 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos See Remarks |
125,000 | $0 | 534,572 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:03 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer |
125,000 | $0 | 167,092 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:03 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director |
27,500 | $0 | 49,500 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:02 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Behanna Heather Director |
27,500 | $0 | 49,500 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:02 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel |
125,000 | $0 | 167,572 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:01 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
27,500 | $0 | 49,500 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:01 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
27,500 | $0 | 49,500 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:00 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer |
125,000 | $0 | 167,572 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:00 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Triola Anna Diaz Chief Commercial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief, Pharma Sciences & MFG. |
3,669 | $2.94 | 42,572 (Direct) |
View |